leadf
logo-loader
viewValiRx PLC

ValiRx Plc celebrating 'particularly important' European patent

ValiRx Plc (LON:VAL) shares rose as it strengthened its worldwide patent protection for lead drug VAL 201 - having been granted a patent by the European office.

Chief operating officer Dr George Morris tells Proactive: ''It's always gratifying to have granted patents rather than just pending patents.''

''On this occasion I think it's particularly important in that all the key markets in which we are currently doing work and are likely to be doing work are now protected and covered for the use and the cancer therapy applications of VAL 201''.

Quick facts: ValiRx PLC

Price: 20.2 GBX

AIM:VAL
Market: AIM
Market Cap: £13.14 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Southern Hemisphere Mining says Llahuin copper gold project has potential to...

Southern Hemisphere Mining Ltd's (ASX:SUH) Mark Stowell speaks to Proactive's Andrew Scott ahead of drill programs at its key projects in Chile - the Llahuin copper gold molybdenum project as well as the Colina2 gold project. The Llahuin copper project hosts a 149Mt @0.41%CuEq resource. Colina2...

8 hours, 47 minutes ago

2 min read